# The Role of Incretins in Obstructive Sleep Apnea “GLP1RAs and GLP1RA/GIPRAs in OSA”

## TL;DR

This paper explores how GLP-1 and dual GLP-1/GIP receptor agonists affect organ systems related to sleep apnea and metabolic health.

## Contribution

It introduces new insights into the mechanisms of GLP1RAs and GLP1RA/GIPRAs in obstructive sleep apnea.

## Key findings

- GLP1RAs and GLP1RA/GIPRAs show potential benefits for organ systems impacted by obstructive sleep apnea.
- These agonists may improve cardiometabolic health in patients with sleep apnea.
- The mechanisms of action involve multiple physiological pathways relevant to sleep apnea.

## Abstract

Mechanisms of action and effects of GLP‐1 receptor agonists and dual GLP‐1/GIP receptor agonists on multiple organ systems relevant to obstructive sleep apnea and cardiometabolic health.